Generation Bio Co. (GBIO)
$5.34+0.00%Close
SELLBEAR · day 3
Key stats
- Market cap
- $36M
- Beta
- 2.01
- P/E (TTM)
- -1.36
- 1W
- -6.32%
- 1M
- -2.55%
- vs SPY 1W
- -6.74%
- vs SPY 1M
- -4.62%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 10
- GROWTH
- 2
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-30.3%
REV YoY-
ROE-50.5%
EPS YoY-
ROA-21.7%
GROSS40
OP-1883
NET-1121
[VALUATION]
P/E TTM-1.36
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B0.71
P/FCF-
EV/EBITDA-1.58
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E51.61
ALTMAN Z-
CURR RATIO4.44
ND/EBITDA-
BETA2.01
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on GBIO?
- LOPJLB’s latest quantitative signal on Generation Bio Co. (GBIO) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is GBIO in?
- Generation Bio Co. (GBIO) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Generation Bio Co. (GBIO) do?
- Generation Bio Co. is a biotechnology firm focused on genetic therapies, working to devise treatments for both uncommon and widespread diseases. The company's current development pipeline includes multiple projects, with a particular emphasis on addressing rare and prevalent conditions affecting the liver and retina. Additionally, it directs its research towards disorders of skeletal muscle, th…